How GSK are revolutionizing HTE

3 Jun 2025

In this case study, ACD/Labs demonstrates how GlaxoSmithKline (GSK) is revolutionizing high-throughput experimentation (HTE) by integrating automation, data analytics, and machine learning into their research workflows. The study highlights GSK's innovative use of digital tools to enhance decision-making and drive more efficient drug discovery.

Links

Tags

High-Throughput ScreeningHigh-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Data AnalysisData analysis hardware and software is available to make data processing straight-forward yet powerful. Data software can be used for math and stats, technical graphing and image analysis. In addition, software is available for specific data analysis of electrophoresis, densitometry, ELISA and DNA sequencing.Software PlatformsSoftware platforms are useful for various stages of laboratory experiments from data collection to data storage and processing. For instance lab software is available for system control, data management, data analysis and qualification / validation.
How GSK are revolutionizing HTE